Table 1.
Experimental groups
Group | N | Genotype | Water | Injection |
---|---|---|---|---|
db/m | 8 | db/m | Regular water | PBS ip, twice a week, starting from week 18 |
db/db | 9 | db/db | Regular water | PBS ip, twice a week, starting from week 18 |
db/db+PAI-1 Ab | 8 | db/db | Regular water | 3 mg/kg BW, PAI-1 antibody ip, twice a week, starting from week 18 |
db/db+Ena+Con Ab | 9 | db/db | 200 mg/l enalapril, starting from week 12 | 3 mg/kg BW, isotope antibody ip, twice a week, starting from week 18 |
db/db+Ena+PAI-1 Ab | 9 | db/db | 200 mg/l enalapril, starting from week 12 | 3 mg/kg BW, PAI-1 antibody ip, twice a week, starting from week 18 |
PAI-1, plasminogen activator inhibitor type 1; ip, intraperitoneally; BW, body wt. See the text for additional definitions.